Inventor · disambiguated record
Melvin Maurice Evers
Also filed as: EVERS MELVIN MAURICE
3 granted patents·8 pending applications·10 citations·filing 2011–2023
66Inventor score
Files withACADEMISCH ZIEKENHUIS LEIDEN5UNIQURE IP BV3UNIQURE BIOPHARMA B V2VAN ROON-MOM WILHELMINA M C1
Top patents by PatentIndex Score
11 records- 0187US10364432B2Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteinsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Granted Jul 30, 2019·7 cites·4 claims
- 0272US9611471B2Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteinsVAN ROON-MOM WILHELMINA M C·Filed 2011·Granted Apr 4, 2017·3 cites·6 claims
- 0370US2020332298A1Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteinsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Application pending·0 cites
- 0468US2020224203A1Antisense oligonucleotide directed removal of proteolytic cleavage sites, the hchwa-d mutation, and trinucleotide repeat expansionsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2020·Application pending·0 cites
- 0561US10590421B2Antisense oligonucleotide directed removal of proteolytic cleavage sites, the HCHWA-D mutation, and trinucleotide repeat expansionsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Granted Mar 17, 2020·0 cites·7 claims
- 0660US2022010314A1Rnai induced reduction of ataxin-3 for the treatment of spinocerebellar ataxia type 3UNIQURE IP BV·Filed 2021·Application pending·0 cites
- 0760US2025230437A1Novel systems for nucleic acid regulationUNIQURE BIOPHARMA B V·Filed 2023·Application pending·0 cites
- 0860US2014039037A1Antisense oligonucleotide directed removal of proteolytic cleavage sites, the hchwa-d mutation, and trinucleotide repeat expansionsACADEMISCH ZIEKENHUIS LEIDEN·Filed 2013·Application pending·0 cites
- 0960US2025297252A1Nucleic acid regulation of SNCAUNIQURE BIOPHARMA B V·Filed 2023·Application pending·0 cites
- 1056US2020199625A1RNAi induced reduction of ataxin-3 for the treatment of Spinocerebellar ataxia type 3UNIQURE IP BV·Filed 2019·Application pending·0 cites
- 1154US2022213482A1Targeting misspliced transcripts in genetic disordersUNIQURE IP BV·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Melvin Maurice Evers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →